EPISODE · Aug 19, 2026 · 1 MIN
Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine
from Minute Briefing · host The Wall Street Journal
Plus: Target’s second-quarter sales suggest the retailer’s turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi’s prediction markets. Alex Ossola hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.
Embed this episode
Ready to play
Moderna Shares Soar on Success of Novel Melanoma Cancer Vaccine
No transcript for this episode yet
Similar Episodes
No similar episodes found.